Visual Predictive Checks for Population PK
Learn how visual predictive checks assess population PK models by comparing observed concentration-time data with simulation-based prediction intervals and understand how to interpret VPCs in pharmacometric model evaluation.
Time-Varying Covariates in PK/PD Models
Learn how time-varying covariates are incorporated into pharmacokinetic and pharmacodynamic models, including changing renal function, biomarkers, disease severity, dosing conditions, and dynamic exposure-response relationships.
Shrinkage in Population PK Models
Learn what shrinkage means in population pharmacokinetic models, why it occurs, how to interpret individual empirical Bayes estimates, how eta and epsilon shrinkage differ, and why shrinkage matters for covariate analysis, diagnostics, and PK/PD modeling.
Residual Unexplained Variability Models
Learn how residual unexplained variability models describe the difference between observed and model-predicted concentrations in population pharmacokinetics, including additive, proportional, combined, exponential, and log-transformed error models.
Renal Function as a PK Covariate
Learn how renal function can be incorporated as a covariate in population pharmacokinetic models, including GFR, creatinine clearance, eGFR, clearance models, scaling, interpretation, and practical modeling considerations.
Prediction-Corrected Visual Predictive Checks
Learn how prediction-corrected visual predictive checks (pcVPCs) diagnose population PK models by correcting observed and simulated concentrations for differences in model-predicted values across time and covariate ranges.
Population PK/PD Simulation with Covariates
Learn how population PK/PD simulation incorporates between-subject variability, covariates, dosing, pharmacokinetics, pharmacodynamics, and uncertainty to predict drug exposure and response across patient populations.
Population PK vs. Traditional Two-Stage Analysis
Compare population pharmacokinetic analysis with traditional two-stage PK analysis, including assumptions, estimation, variability, covariates, sparse data, and practical model selection.
Population PK for Regulatory Decision Making
Learn how population pharmacokinetic models characterize PK variability, identify covariate effects, support dose selection and individualization, and provide evidence for regulatory decision making.
Normalized Prediction Distribution Errors
Learn how Normalized Prediction Distribution Errors (NPDE) evaluate population PK model adequacy by comparing observed concentrations with simulated prediction distributions.